Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-16 Sale | 2021-09-20 5:02 pm | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 6,238 | $6.73 | $41,982 | 13,762 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-07 Option Award | 2024-06-11 4:21 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 15,900 | $0 | 21,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:23 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 3,000 | $0.94 | 19,762 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:10 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-21 4:45 pm | N/A 2032-06-16 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 4,375 | $0 | 4,375 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:05 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 3,000 | $0.99 | 16,762 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:17 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-03-11 Option Award(A) | 2022-04-04 7:09 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-14 5:25 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:20 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 7:41 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 4:33 pm | N/A 2031-07-05 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2021-07-08 4:32 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |